RETA : Reata Pharmaceuticals stock forecast, predictions, and share price target for 2022, 2023 (1 year) to 2025 - 2027 (5 year) to 2030, and 2032 (10 year) with Revenue and EPS Prognosis by Technical Analysis
| year | Average | Low | High | Change from close on 2023-09-26 |
|---|---|---|---|---|
| 2023 | $175.62 | $174.62 | $176.61 | 1.89% |
| 2024 | $183.25 | $178.35 | $186.05 | 6.32% |
| 2025 | $166.42 | $141.38 | $180.76 | -3.45% |
| 2026 | $121.73 | $111.96 | $135.38 | -29.37% |
| 2027 | $103.86 | $94.97 | $110.08 | -39.74% |
| 2028 | $72.91 | $61.36 | $90.83 | -57.7% |
| 2029 | $58.88 | $58.05 | $60.54 | -65.84% |
| 2030 | $67.12 | $60.29 | $73.05 | -61.06% |
| 2031 | $65.83 | $53.97 | $73.15 | -61.8% |
| 2032 | $52.54 | $50.67 | $57.45 | -69.52% |
| 2033 | $73.11 | $59.85 | $85.08 | -57.58% |
The 15 Wall Street analysts offering Reata Pharmaceuticals stock forecast in the last 6 months have average price target of
$144.13 with a high forecast of $173.0 and a low forecast of $98.0.
The average Reata Pharmaceuticals stock forecast represents a -16.38%
decrease from the last price of $172.360000610352.
From AI system, total return is 2366.52% from 4098 forecasts.
For Reata Pharmaceuticals stock forecast for 2023, 2 predictions are offered for each month of 2023 with average Reata Pharmaceuticals stock
forecast of $175.62, a high forecast of $176.61, and a low forecast of $174.62.
The average Reata Pharmaceuticals stock forecast 2023 represents a 1.89%
increase from the last price of $172.360000610352.
For Reata Pharmaceuticals stock forecast for 2024, 12 predictions are offered for each month of 2024 with average Reata Pharmaceuticals stock
forecast of $183.25, a high forecast of $186.05, and a low forecast of $178.35.
The average Reata Pharmaceuticals stock forecast 2024 represents a 6.32%
increase from the last price of $172.360000610352.
For Reata Pharmaceuticals stock forecast for 2026, 12 predictions are offered for each month of 2026 with average Reata Pharmaceuticals stock
forecast of $121.73, a high forecast of $135.38, and a low forecast of $111.96.
The average Reata Pharmaceuticals stock forecast 2026 represents a -29.37%
decrease from the last price of $172.360000610352.
For Reata Pharmaceuticals stock forecast for 2028 (5 year), 12 predictions are offered for each month of 2028 with average Reata Pharmaceuticals stock
forecast of $72.91, a high forecast of $90.83, and a low forecast of $61.36.
The average Reata Pharmaceuticals stock forecast 2028 represents a -57.7%
decrease from the last price of $172.360000610352.
For Reata Pharmaceuticals stock forecast for 2031, 12 predictions are offered for each month of 2031 with average Reata Pharmaceuticals stock
forecast of $65.83, a high forecast of $73.15, and a low forecast of $53.97.
The average Reata Pharmaceuticals stock forecast 2031 represents a -61.8%
decrease from the last price of $172.360000610352.
For Reata Pharmaceuticals stock forecast for 2033 (10 year), 10 predictions are offered for each month of 2033 with average Reata Pharmaceuticals stock
forecast of $73.11, a high forecast of $85.08, and a low forecast of $59.85.
The average Reata Pharmaceuticals stock forecast 2033 represents a -57.58%
decrease from the last price of $172.360000610352.
Please, see more forecasts below.
RETA : Reata Pharmaceuticals stock forecast by Wall Street Analysts
The average Reata Pharmaceuticals stock forecast from last 6 month is $144.13, and this show a 39.76% increase in average from the prior price target of the each prediction. Also, this average forecast of $144.13 represents a 49.84% increase from the past average forecast of $96.19, 6 months ago from 16 wall street analysts.
Reata Pharmaceuticals stock forecast for upcoming days
| Date | Price Target | Change |
|---|---|---|
| 2023-09-27 | $170.40 | -1.13% |
| 2023-09-28 | $157.66 | -7.48% |
| 2023-09-29 | $144.72 | -8.21% |
| 2023-10-02 | $141.62 | -2.14% |
| 2023-10-03 | $139.75 | -1.32% |
RETA : Long term Reata Pharmaceuticals stock forecast for 2022, 2023 (1 year) - 2025 - 2027 (5 year) - 2030, and 2032 (10 year)
Forecast for 2023 Nov. is $174.62 , for 2024 Oct. is $185.47 , for 2027 Oct. is $101.39 , for 2028 Oct. is $63.63 , for 2032 Oct. is $53.93 , and for 2033 Oct. is $85.08.
RETA : Reata Pharmaceuticals stock forecast for 2023
| Date | Price Target | Change |
|---|---|---|
| 2023 Nov. | $174.62 | 1.31% |
| 2023 Dec. | $176.61 | 1.14% |
RETA : Reata Pharmaceuticals stock forecast for 2024
| Date | Price Target | Change |
|---|---|---|
| 2024 Jan. | $178.35 | 0.99% |
| 2024 Feb. | $179.70 | 0.76% |
| 2024 Mar. | $180.97 | 0.71% |
| 2024 Apr. | $182.35 | 0.76% |
| 2024 May. | $183.65 | 0.71% |
| 2024 Jun. | $184.66 | 0.55% |
| 2024 Jul. | $185.52 | 0.47% |
| 2024 Aug. | $185.96 | 0.24% |
| 2024 Sep. | $186.05 | 0.05% |
| 2024 Oct. | $185.47 | -0.31% |
| 2024 Nov. | $183.92 | -0.84% |
| 2024 Dec. | $182.34 | -0.86% |
RETA : Reata Pharmaceuticals stock forecast for 2025
| Date | Price Target | Change |
|---|---|---|
| 2025 Jan. | $180.76 | -0.87% |
| 2025 Feb. | $179.08 | -0.93% |
| 2025 Mar. | $177.32 | -0.98% |
| 2025 Apr. | $175.50 | -1.03% |
| 2025 May. | $173.42 | -1.18% |
| 2025 Jun. | $171.35 | -1.19% |
| 2025 Jul. | $168.97 | -1.39% |
| 2025 Aug. | $165.49 | -2.06% |
| 2025 Sep. | $160.66 | -2.92% |
| 2025 Oct. | $154.86 | -3.61% |
| 2025 Nov. | $148.20 | -4.30% |
| 2025 Dec. | $141.38 | -4.60% |
RETA : Reata Pharmaceuticals stock forecast for 2026
| Date | Price Target | Change |
|---|---|---|
| 2026 Jan. | $135.38 | -4.25% |
| 2026 Feb. | $130.28 | -3.76% |
| 2026 Mar. | $126.79 | -2.68% |
| 2026 Apr. | $125.41 | -1.08% |
| 2026 May. | $123.91 | -1.20% |
| 2026 Jun. | $122.15 | -1.42% |
| 2026 Jul. | $120.41 | -1.42% |
| 2026 Aug. | $118.65 | -1.46% |
| 2026 Sep. | $116.92 | -1.46% |
| 2026 Oct. | $115.25 | -1.42% |
| 2026 Nov. | $113.65 | -1.39% |
| 2026 Dec. | $111.96 | -1.48% |
RETA : Reata Pharmaceuticals stock forecast for 2027
| Date | Price Target | Change |
|---|---|---|
| 2027 Jan. | $110.08 | -1.69% |
| 2027 Feb. | $108.14 | -1.76% |
| 2027 Mar. | $106.51 | -1.51% |
| 2027 Apr. | $105.48 | -0.97% |
| 2027 May. | $105.07 | -0.38% |
| 2027 Jun. | $104.68 | -0.37% |
| 2027 Jul. | $104.36 | -0.31% |
| 2027 Aug. | $103.95 | -0.40% |
| 2027 Sep. | $103.10 | -0.81% |
| 2027 Oct. | $101.39 | -1.66% |
| 2027 Nov. | $98.61 | -2.74% |
| 2027 Dec. | $94.97 | -3.70% |
RETA : Reata Pharmaceuticals stock forecast for 2028
| Date | Price Target | Change |
|---|---|---|
| 2028 Jan. | $90.83 | -4.36% |
| 2028 Feb. | $86.57 | -4.69% |
| 2028 Mar. | $82.45 | -4.76% |
| 2028 Apr. | $78.64 | -4.63% |
| 2028 May. | $75.19 | -4.38% |
| 2028 Jun. | $72.13 | -4.08% |
| 2028 Jul. | $69.44 | -3.72% |
| 2028 Aug. | $67.14 | -3.32% |
| 2028 Sep. | $65.20 | -2.88% |
| 2028 Oct. | $63.63 | -2.42% |
| 2028 Nov. | $62.36 | -1.98% |
| 2028 Dec. | $61.36 | -1.61% |
RETA : Reata Pharmaceuticals stock forecast for 2029
| Date | Price Target | Change |
|---|---|---|
| 2029 Jan. | $60.54 | -1.33% |
| 2029 Feb. | $59.86 | -1.12% |
| 2029 Mar. | $59.28 | -0.96% |
| 2029 Apr. | $58.80 | -0.81% |
| 2029 May. | $58.43 | -0.64% |
| 2029 Jun. | $58.18 | -0.44% |
| 2029 Jul. | $58.05 | -0.21% |
| 2029 Aug. | $58.08 | 0.04% |
| 2029 Sep. | $58.24 | 0.28% |
| 2029 Oct. | $58.54 | 0.51% |
| 2029 Nov. | $58.98 | 0.75% |
| 2029 Dec. | $59.56 | 0.99% |
RETA : Reata Pharmaceuticals stock forecast for 2030
| Date | Price Target | Change |
|---|---|---|
| 2030 Jan. | $60.29 | 1.24% |
| 2030 Feb. | $61.20 | 1.49% |
| 2030 Mar. | $62.27 | 1.76% |
| 2030 Apr. | $63.54 | 2.03% |
| 2030 May. | $64.99 | 2.28% |
| 2030 Jun. | $66.57 | 2.43% |
| 2030 Jul. | $68.18 | 2.42% |
| 2030 Aug. | $69.69 | 2.22% |
| 2030 Sep. | $70.98 | 1.85% |
| 2030 Oct. | $71.98 | 1.41% |
| 2030 Nov. | $72.67 | 0.95% |
| 2030 Dec. | $73.05 | 0.52% |
RETA : Reata Pharmaceuticals stock forecast for 2031
| Date | Price Target | Change |
|---|---|---|
| 2031 Jan. | $73.15 | 0.14% |
| 2031 Feb. | $72.98 | -0.23% |
| 2031 Mar. | $72.53 | -0.62% |
| 2031 Apr. | $71.76 | -1.07% |
| 2031 May. | $70.59 | -1.63% |
| 2031 Jun. | $68.95 | -2.33% |
| 2031 Jul. | $66.77 | -3.16% |
| 2031 Aug. | $64.10 | -4.00% |
| 2031 Sep. | $61.14 | -4.61% |
| 2031 Oct. | $58.26 | -4.70% |
| 2031 Nov. | $55.82 | -4.20% |
| 2031 Dec. | $53.97 | -3.30% |
RETA : Reata Pharmaceuticals stock forecast for 2032
| Date | Price Target | Change |
|---|---|---|
| 2032 Jan. | $52.70 | -2.36% |
| 2032 Feb. | $51.84 | -1.63% |
| 2032 Mar. | $51.25 | -1.14% |
| 2032 Apr. | $50.86 | -0.76% |
| 2032 May. | $50.67 | -0.36% |
| 2032 Jun. | $50.74 | 0.13% |
| 2032 Jul. | $51.08 | 0.67% |
| 2032 Aug. | $51.72 | 1.25% |
| 2032 Sep. | $52.66 | 1.82% |
| 2032 Oct. | $53.93 | 2.42% |
| 2032 Nov. | $55.53 | 2.96% |
| 2032 Dec. | $57.45 | 3.47% |
RETA : Reata Pharmaceuticals stock forecast for 2033
| Date | Price Target | Change |
|---|---|---|
| 2033 Jan. | $59.85 | 4.17% |
| 2033 Feb. | $62.78 | 4.90% |
| 2033 Mar. | $66.09 | 5.27% |
| 2033 Apr. | $69.43 | 5.05% |
| 2033 May. | $72.50 | 4.42% |
| 2033 Jun. | $75.21 | 3.74% |
| 2033 Jul. | $77.66 | 3.24% |
| 2033 Aug. | $80.02 | 3.04% |
| 2033 Sep. | $82.48 | 3.08% |
| 2033 Oct. | $85.08 | 3.14% |
Frequently Asked Questions about Reata Pharmaceuticals stock forecast
Is Reata Pharmaceuticals a good long term stock?
From Reata Pharmaceuticals stock forecast , Reata Pharmaceuticals (RETA) stock can be a good investment choice. According to Tudal, the Reata Pharmaceuticals stock price forecast for 2023 Nov. is $174.621982756474 From Reata Pharmaceuticals stock forecast , Reata Pharmaceuticals (RETA) stock can be a good investment choice. According to Tudal, the Reata Pharmaceuticals stock price forecast for 2024 Oct. is $185.47382247911 From Reata Pharmaceuticals stock forecast , Reata Pharmaceuticals (RETA) stock cannot be a good investment choice. According to Tudal, the Reata Pharmaceuticals stock price forecast for 2027 Oct. is $101.388645488542 From Reata Pharmaceuticals stock forecast , Reata Pharmaceuticals (RETA) stock cannot be a good investment choice. According to Tudal, the Reata Pharmaceuticals stock price forecast for 2028 Oct. is $63.6265517919444 From Reata Pharmaceuticals stock forecast , Reata Pharmaceuticals (RETA) stock cannot be a good investment choice. According to Tudal, the Reata Pharmaceuticals stock price forecast for 2032 Oct. is $53.9333649134647 From Reata Pharmaceuticals stock forecast , Reata Pharmaceuticals (RETA) stock cannot be a good investment choice. According to Tudal, the Reata Pharmaceuticals stock price forecast for 2033 Oct. is $85.077652172442
Is Reata Pharmaceuticals stock overvalued?
Reata Pharmaceuticals (RETA) stock is expected to go UP . Therefore, Tudal would say that Reata Pharmaceuticals (RETA) stock is NOT overvalued.
Will Reata Pharmaceuticals stock price go up?
Yes. The Reata Pharmaceuticals stock price forecast for 2024 Oct. is $185.47382247911
Is Reata Pharmaceuticals stock a good buy now?
Since closing price on 2023-09-26 is $172.360000610352 and forecast for 2024 Oct. is $185.47, Reata Pharmaceuticals stock is a good 1 year investment.